Annual Current Liabilities
$33.09 M
+$4.25 M+14.72%
31 December 2023
Summary:
Krystal Biotech annual total current liabilities is currently $33.09 million, with the most recent change of +$4.25 million (+14.72%) on 31 December 2023. During the last 3 years, it has risen by +$7.36 million (+28.59%). KRYS annual current liabilities is now at all-time high.KRYS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$89.53 M
+$17.68 M+24.60%
30 September 2024
Summary:
Krystal Biotech quarterly total current liabilities is currently $89.53 million, with the most recent change of +$17.68 million (+24.60%) on 30 September 2024. Over the past year, it has increased by +$56.43 million (+170.52%). KRYS quarterly current liabilities is now at all-time high.KRYS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KRYS Current Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +170.5% |
3 y3 years | +28.6% | +247.9% |
5 y5 years | +894.7% | +2590.9% |
KRYS Current Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +28.6% | at high | +274.6% |
5 y | 5 years | at high | +894.7% | at high | +2590.9% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Krystal Biotech Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $89.53 M(+24.6%) |
June 2024 | - | $71.85 M(+51.0%) |
Mar 2024 | - | $47.59 M(+43.8%) |
Dec 2023 | $33.09 M(+14.7%) | $33.09 M(+20.0%) |
Sept 2023 | - | $27.58 M(+15.4%) |
June 2023 | - | $23.90 M(-31.9%) |
Mar 2023 | - | $35.08 M(+21.6%) |
Dec 2022 | $28.85 M(+12.1%) | $28.85 M(+2.9%) |
Sept 2022 | - | $28.03 M(-18.6%) |
June 2022 | - | $34.43 M(-43.0%) |
Mar 2022 | - | $60.44 M(+134.8%) |
Dec 2021 | $25.74 M(+66.6%) | $25.74 M(-28.1%) |
Sept 2021 | - | $35.78 M(+97.5%) |
June 2021 | - | $18.12 M(+98.2%) |
Mar 2021 | - | $9.14 M(-40.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2020 | $15.45 M(+364.4%) | $15.45 M(+114.7%) |
Sept 2020 | - | $7.20 M(+23.4%) |
June 2020 | - | $5.83 M(+43.6%) |
Mar 2020 | - | $4.06 M(+22.1%) |
Dec 2019 | $3.33 M(+28.2%) | $3.33 M(-10.7%) |
Sept 2019 | - | $3.73 M(-5.4%) |
June 2019 | - | $3.94 M(+21.5%) |
Mar 2019 | - | $3.24 M(+24.9%) |
Dec 2018 | $2.60 M(+305.6%) | $2.60 M(+35.5%) |
Sept 2018 | - | $1.92 M(+152.4%) |
June 2018 | - | $759.00 K(+67.9%) |
Mar 2018 | - | $452.00 K(-29.4%) |
Dec 2017 | $640.00 K(+1388.4%) | $640.00 K(-74.1%) |
Sept 2017 | - | $2.48 M(+323.8%) |
June 2017 | - | $584.00 K(+1258.1%) |
Dec 2016 | $43.00 K | $43.00 K |
FAQ
- What is Krystal Biotech annual total current liabilities?
- What is the all time high annual current liabilities for Krystal Biotech?
- What is Krystal Biotech quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Krystal Biotech?
- What is Krystal Biotech quarterly current liabilities year-on-year change?
What is Krystal Biotech annual total current liabilities?
The current annual current liabilities of KRYS is $33.09 M
What is the all time high annual current liabilities for Krystal Biotech?
Krystal Biotech all-time high annual total current liabilities is $33.09 M
What is Krystal Biotech quarterly total current liabilities?
The current quarterly current liabilities of KRYS is $89.53 M
What is the all time high quarterly current liabilities for Krystal Biotech?
Krystal Biotech all-time high quarterly total current liabilities is $89.53 M
What is Krystal Biotech quarterly current liabilities year-on-year change?
Over the past year, KRYS quarterly total current liabilities has changed by +$56.43 M (+170.52%)